BACKGROUND: Current surveillance guidelines for patients with long-standing ulcerative colitis (UC) recommend repeated colonoscopy with random biopsies, which is time-consuming, discomforting, and expensive. A less invasive strategy is to identify neoplasia by analyzing biomarkers from the more accessible rectum to predict the need for a full colonoscopy. The goal of this pilot study was to evaluate whether optical markers of rectal mucosa derived from a novel optical technique, partial-wave spectroscopic microscopy (PWS), could identify UC patients with high-grade dysplasia (HGD) or cancer (CA) present anywhere in their colon. METHODS: Banked frozen nondysplastic mucosal rectal biopsies were used from 28 UC patients (15 without dysplasia and 13 with concurrent HGD or CA). The specimen slides were made using a touch prep method and underwent PWS analysis. We divided the patients into two groups: 13 as a training set and an independent 15 as a validation set. RESULTS: We identified six optical markers, ranked by measuring the information gain with respect to the outcome of cancer. The most effective markers were selected by maximizing the cross-validated training accuracy of a Naive Bayes classifier. The optimal classifier was applied to the validation data yielding 100% sensitivity and 75% specificity. CONCLUSIONS: Our results indicate that the PWS-derived optical markers can accurately predict UC patients with HGD/CA through assessment of rectal epithelial cells. By aiming for high sensitivity, our approach could potentially simplify the surveillance of UC patients and improve overall resource utilization by identifying patients with HGD/CA who should proceed with colonoscopy.
BACKGROUND: Current surveillance guidelines for patients with long-standing ulcerative colitis (UC) recommend repeated colonoscopy with random biopsies, which is time-consuming, discomforting, and expensive. A less invasive strategy is to identify neoplasia by analyzing biomarkers from the more accessible rectum to predict the need for a full colonoscopy. The goal of this pilot study was to evaluate whether optical markers of rectal mucosa derived from a novel optical technique, partial-wave spectroscopic microscopy (PWS), could identify UC patients with high-grade dysplasia (HGD) or cancer (CA) present anywhere in their colon. METHODS: Banked frozen nondysplastic mucosal rectal biopsies were used from 28 UC patients (15 without dysplasia and 13 with concurrent HGD or CA). The specimen slides were made using a touch prep method and underwent PWS analysis. We divided the patients into two groups: 13 as a training set and an independent 15 as a validation set. RESULTS: We identified six optical markers, ranked by measuring the information gain with respect to the outcome of cancer. The most effective markers were selected by maximizing the cross-validated training accuracy of a Naive Bayes classifier. The optimal classifier was applied to the validation data yielding 100% sensitivity and 75% specificity. CONCLUSIONS: Our results indicate that the PWS-derived optical markers can accurately predict UC patients with HGD/CA through assessment of rectal epithelial cells. By aiming for high sensitivity, our approach could potentially simplify the surveillance of UC patients and improve overall resource utilization by identifying patients with HGD/CA who should proceed with colonoscopy.
Authors: K Holzmann; M Weis-Klemm; B Klump; C J Hsieh; F Borchard; M Gregor; R Porschen Journal: Scand J Gastroenterol Date: 2001-12 Impact factor: 2.423
Authors: Lanlan Shen; Yutaka Kondo; Gary L Rosner; Lianchun Xiao; Natalie Supunpong Hernandez; Jill Vilaythong; P Scott Houlihan; Robert S Krouse; Anil R Prasad; Janine G Einspahr; Julie Buckmeier; David S Alberts; Stanley R Hamilton; Jean-Pierre J Issa Journal: J Natl Cancer Inst Date: 2005-09-21 Impact factor: 13.506
Authors: Fumiaki Sato; Noam Harpaz; David Shibata; Yan Xu; Jing Yin; Yuriko Mori; Tong-Tong Zou; Suna Wang; Kena Desai; Anatoly Leytin; Florin M Selaru; John M Abraham; Stephen J Meltzer Journal: Cancer Res Date: 2002-02-15 Impact factor: 12.701
Authors: Hariharan Subramanian; Prabhakar Pradhan; Yang Liu; Ilker R Capoglu; Xu Li; Jeremy D Rogers; Alexander Heifetz; Dhananjay Kunte; Hemant K Roy; Allen Taflove; Vadim Backman Journal: Proc Natl Acad Sci U S A Date: 2008-12-10 Impact factor: 11.205
Authors: Teresa A Brentnall; Sheng Pan; Mary P Bronner; David A Crispin; Hamid Mirzaei; Kelly Cooke; Yasuko Tamura; Tatiana Nikolskaya; Lellean Jebailey; David R Goodlett; Martin McIntosh; Ruedi Aebersold; Peter S Rabinovitch; Ru Chen Journal: Proteomics Clin Appl Date: 2009-09-14 Impact factor: 3.494
Authors: Matthew Rutter; Brian Saunders; Kay Wilkinson; Steve Rumbles; Gillian Schofield; Michael Kamm; Christopher Williams; Ashley Price; Ian Talbot; Alastair Forbes Journal: Gastroenterology Date: 2004-02 Impact factor: 22.682
Authors: Rajan K Bista; Shikhar Uttam; Douglas J Hartman; Wei Qiu; Jian Yu; Lin Zhang; Randall E Brand; Yang Liu Journal: J Biomed Opt Date: 2012-06 Impact factor: 3.170
Authors: Rajan K Bista; Pin Wang; Rohit Bhargava; Shikhar Uttam; Douglas J Hartman; Randall E Brand; Yang Liu Journal: Breast Cancer Res Treat Date: 2012-06-16 Impact factor: 4.872
Authors: Douglas J Hartman; Alyssa M Krasinskas; Shikhar Uttam; Kevin Staton; Rajan Bista; Sumera Rizvi; Adam Slivka; Randall Brand; Yang Liu Journal: Am J Clin Pathol Date: 2014-06 Impact factor: 2.493
Authors: Kenneth E Fasanella; Rajan K Bista; Kevin Staton; Sumera Rizvi; Shikhar Uttam; Chengquan Zhao; Antonia Sepulveda; Randall E Brand; Kevin McGrath; Yang Liu Journal: J Cancer Date: 2013-09-10 Impact factor: 4.207
Authors: Shikhar Uttam; Rajan K Bista; Kevin Staton; Sergey Alexandrov; Serah Choi; Christopher J Bakkenist; Douglas J Hartman; Randall E Brand; Yang Liu Journal: Biomed Opt Express Date: 2013-03-22 Impact factor: 3.732